Lidocaine versus ropivacaine for postoperative continuous paravertebral nerve blocks in patients undergoing laparoscopic bowel surgery: a randomized, controlled, double-blinded, pilot study
BACKGROUND AND OBJECTIVES: Lidocaine could provide many advantages in continuous regional anesthesia techniques, including faster onset, greater titratability, and lower cost than long-acting local anesthetics. This prospective, randomized, double-blinded, pilot study is therefore intended to compar...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574900/ https://www.ncbi.nlm.nih.gov/pubmed/26396544 http://dx.doi.org/10.2147/LRA.S84476 |
_version_ | 1782390688182173696 |
---|---|
author | Ghisi, Daniela Fanelli, Andrea Jouguelet-Lacoste, Julie La Colla, Luca Auroux, Anne-Sophie Chelly, Jacques E |
author_facet | Ghisi, Daniela Fanelli, Andrea Jouguelet-Lacoste, Julie La Colla, Luca Auroux, Anne-Sophie Chelly, Jacques E |
author_sort | Ghisi, Daniela |
collection | PubMed |
description | BACKGROUND AND OBJECTIVES: Lidocaine could provide many advantages in continuous regional anesthesia techniques, including faster onset, greater titratability, and lower cost than long-acting local anesthetics. This prospective, randomized, double-blinded, pilot study is therefore intended to compare lidocaine to ropivacaine in bilateral continuous paravertebral blocks using a multimodal approach for postoperative pain management following laparoscopic bowel surgery. METHODS: Thirty-five ASA I–III consecutive patients undergoing elective laparoscopic bowel surgery and bilateral thoracic paravertebral continuous blocks were analyzed: bilateral thoracic paravertebral infusions of ropivacaine 0.2% (Group Ropi, n=18) or lidocaine 0.25% (Group Lido, n=17) were started at 7 mL/h in the postanesthesia care unit. For each patient, we collected numerical rating scores (NRS) for pain at rest and during movement at baseline, at postanesthesia care unit discharge, at 24 hours and 48 hours after the end of surgery, as well as hydromorphone patient-controlled analgesia requirements, local anesthetic consumption, side effects, postoperative complications, and functional outcomes. RESULTS: No effect of group distribution on NRS scores for pain at rest or at movement (P=0.823 and P=0.146), nor on hydromorphone (P=0.635) or local anesthetic consumption (P=0.063) was demonstrated at any analyzed time point. Hospital length of stay and spontaneous ambulation were comparable between groups (P=0.636 and P=0.148). In the context of a multimodal approach, the two drugs showed comparable safety profiles. DISCUSSION: Lidocaine 0.25% and ropivacaine 0.2% provided similar analgesic profiles after elective abdominal surgeries, without any difference in terms of functional outcomes. The easier titratability of lidocaine together with its lower cost induced our clinical practice to definitely switch from ropivacaine to lidocaine for postoperative bilateral paravertebral continuous infusions. |
format | Online Article Text |
id | pubmed-4574900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-45749002015-09-22 Lidocaine versus ropivacaine for postoperative continuous paravertebral nerve blocks in patients undergoing laparoscopic bowel surgery: a randomized, controlled, double-blinded, pilot study Ghisi, Daniela Fanelli, Andrea Jouguelet-Lacoste, Julie La Colla, Luca Auroux, Anne-Sophie Chelly, Jacques E Local Reg Anesth Original Research BACKGROUND AND OBJECTIVES: Lidocaine could provide many advantages in continuous regional anesthesia techniques, including faster onset, greater titratability, and lower cost than long-acting local anesthetics. This prospective, randomized, double-blinded, pilot study is therefore intended to compare lidocaine to ropivacaine in bilateral continuous paravertebral blocks using a multimodal approach for postoperative pain management following laparoscopic bowel surgery. METHODS: Thirty-five ASA I–III consecutive patients undergoing elective laparoscopic bowel surgery and bilateral thoracic paravertebral continuous blocks were analyzed: bilateral thoracic paravertebral infusions of ropivacaine 0.2% (Group Ropi, n=18) or lidocaine 0.25% (Group Lido, n=17) were started at 7 mL/h in the postanesthesia care unit. For each patient, we collected numerical rating scores (NRS) for pain at rest and during movement at baseline, at postanesthesia care unit discharge, at 24 hours and 48 hours after the end of surgery, as well as hydromorphone patient-controlled analgesia requirements, local anesthetic consumption, side effects, postoperative complications, and functional outcomes. RESULTS: No effect of group distribution on NRS scores for pain at rest or at movement (P=0.823 and P=0.146), nor on hydromorphone (P=0.635) or local anesthetic consumption (P=0.063) was demonstrated at any analyzed time point. Hospital length of stay and spontaneous ambulation were comparable between groups (P=0.636 and P=0.148). In the context of a multimodal approach, the two drugs showed comparable safety profiles. DISCUSSION: Lidocaine 0.25% and ropivacaine 0.2% provided similar analgesic profiles after elective abdominal surgeries, without any difference in terms of functional outcomes. The easier titratability of lidocaine together with its lower cost induced our clinical practice to definitely switch from ropivacaine to lidocaine for postoperative bilateral paravertebral continuous infusions. Dove Medical Press 2015-09-14 /pmc/articles/PMC4574900/ /pubmed/26396544 http://dx.doi.org/10.2147/LRA.S84476 Text en © 2015 Ghisi et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Ghisi, Daniela Fanelli, Andrea Jouguelet-Lacoste, Julie La Colla, Luca Auroux, Anne-Sophie Chelly, Jacques E Lidocaine versus ropivacaine for postoperative continuous paravertebral nerve blocks in patients undergoing laparoscopic bowel surgery: a randomized, controlled, double-blinded, pilot study |
title | Lidocaine versus ropivacaine for postoperative continuous paravertebral nerve blocks in patients undergoing laparoscopic bowel surgery: a randomized, controlled, double-blinded, pilot study |
title_full | Lidocaine versus ropivacaine for postoperative continuous paravertebral nerve blocks in patients undergoing laparoscopic bowel surgery: a randomized, controlled, double-blinded, pilot study |
title_fullStr | Lidocaine versus ropivacaine for postoperative continuous paravertebral nerve blocks in patients undergoing laparoscopic bowel surgery: a randomized, controlled, double-blinded, pilot study |
title_full_unstemmed | Lidocaine versus ropivacaine for postoperative continuous paravertebral nerve blocks in patients undergoing laparoscopic bowel surgery: a randomized, controlled, double-blinded, pilot study |
title_short | Lidocaine versus ropivacaine for postoperative continuous paravertebral nerve blocks in patients undergoing laparoscopic bowel surgery: a randomized, controlled, double-blinded, pilot study |
title_sort | lidocaine versus ropivacaine for postoperative continuous paravertebral nerve blocks in patients undergoing laparoscopic bowel surgery: a randomized, controlled, double-blinded, pilot study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574900/ https://www.ncbi.nlm.nih.gov/pubmed/26396544 http://dx.doi.org/10.2147/LRA.S84476 |
work_keys_str_mv | AT ghisidaniela lidocaineversusropivacaineforpostoperativecontinuousparavertebralnerveblocksinpatientsundergoinglaparoscopicbowelsurgeryarandomizedcontrolleddoubleblindedpilotstudy AT fanelliandrea lidocaineversusropivacaineforpostoperativecontinuousparavertebralnerveblocksinpatientsundergoinglaparoscopicbowelsurgeryarandomizedcontrolleddoubleblindedpilotstudy AT jougueletlacostejulie lidocaineversusropivacaineforpostoperativecontinuousparavertebralnerveblocksinpatientsundergoinglaparoscopicbowelsurgeryarandomizedcontrolleddoubleblindedpilotstudy AT lacollaluca lidocaineversusropivacaineforpostoperativecontinuousparavertebralnerveblocksinpatientsundergoinglaparoscopicbowelsurgeryarandomizedcontrolleddoubleblindedpilotstudy AT aurouxannesophie lidocaineversusropivacaineforpostoperativecontinuousparavertebralnerveblocksinpatientsundergoinglaparoscopicbowelsurgeryarandomizedcontrolleddoubleblindedpilotstudy AT chellyjacquese lidocaineversusropivacaineforpostoperativecontinuousparavertebralnerveblocksinpatientsundergoinglaparoscopicbowelsurgeryarandomizedcontrolleddoubleblindedpilotstudy |